EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Arp2/3 Inhibition Synergizes With PARP Inhibitors by Impairing Homologous Recombination in Gastric Cancer Cells

Wenlong Li, Xinyue Pei, Yongpei Li, Yanji Lu, Xian Hong, Ming Sui, Qiang Li, Xueying Sun, Jingqiu Wang, Enming Zhang, Yihan Liu, Tao Wang and 2 more

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl51619 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, 2026. Written by Wenlong Li and 13 co-authors. Institution: Laboratory of Protein Structure and Function, Institute of Medicine and Pharmacy, Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China. Major MEDLINE topics: Poly(ADP-ribose) Polymerase Inhibitors, Stomach Neoplasms, Actin-Related Protein 2-3 Complex, Homologous Recombination. Cited 1 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: Heilongjiang Provincial Natural Science Foundation of China, Qiqihar Medical Institute Foundation, Education Department Foundation of Heilongjiang Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background:Poly(ADP-ribose) polymerase inhibitors (PARPi) have shown limited efficacy in gastric cancer, primarily due to the rarity of inherent homologous recombination (HR) deficiency. The nuclear Arp2/3 complex was recently implicated in DNA double-strand break repair via HR. Here, we investigate whether pharmacological inhibition of Arp2/3 can induce a functional HR-deficient state to synergize with PARPi in gastric cancer cells.Methods:HR repair efficiency was assessed using a direct repeat green fluorescent protein (DR-GFP) reporter assay in HEK-293T cells following Arp2/3 inhibition with CK666, siRNA-mediated knockdown, or CRISPR/Cas9-mediated knockout of ACTR2/ACTR3. HGC-27 and AGS gastric cancer cells were treated with CK666 alone and in combination with olaparib or niraparib. Cell viability and synergy were evaluated by Cell Counting Kit-8 (CCK-8) and clonogenic assays (n = 3 independent experiments). DNA damage and apoptosis were assessed by immunofluorescence for gamma H2A histone family member X (γH2AX) foci (≥100 cells per condition) and Western blot analysis for cleaved PARP.Results:Arp2/3 inhibition with CK666 significantly impaired HR repair efficiency in the DR-GFP assay (p < 0.01). This effect was recapitulated by genetic knockdown or knockout of ACTR2/ACTR3. CK666 alone exerted minimal cytotoxicity, but synergized with both olaparib and niraparib to suppress proliferation (Combination Index

Subjects

MeSH terms (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsStomach NeoplasmsActin-Related Protein 2-3 ComplexHomologous RecombinationHumansPhthalazinesPiperazinesCell Line, TumorDrug SynergismHEK293 CellsPiperidinesIndazoles

Author keywords

actin-related protein 2-3 complexhomologous recombinationpoly(ADP-ribose) polymerase inhibitorsstomach neoplasmssynthetic lethality

Substances

Poly(ADP-ribose) Polymerase InhibitorsPhthalazinesPiperazinesolaparibActin-Related Protein 2-3 ComplexPiperidinesniraparibIndazoles

Authors and institutions

  • Laboratory of Protein Structure and Function, Institute of Medicine and Pharmacy, Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China.
  • School of Medical Technology, Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China.
  • School of Basic Medical Sciences, Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China.
  • Department of Gastroenterology, The First Hospital of Qiqihar, 161005 Qiqihar, Heilongjiang, China.

Funding

  • Heilongjiang Provincial Natural Science Foundation of China
  • Qiqihar Medical Institute Foundation
  • Education Department Foundation of Heilongjiang Province
  • Construction Project of Dominant Characteristic Disciplines of Qiqihar Medical University

Cite

APA

Li, W., Pei, X., Li, Y., Lu, Y., Hong, X., Sui, M., Li, Q., Sun, X., Wang, J., Zhang, E., Liu, Y., Wang, T., Xu, J., & Deng, Z. (2026). Arp2/3 Inhibition Synergizes With PARP Inhibitors by Impairing Homologous Recombination in Gastric Cancer Cells. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl51619

Vancouver

Li W, Pei X, Li Y, Lu Y, Hong X, Sui M, et al. Arp2/3 Inhibition Synergizes With PARP Inhibitors by Impairing Homologous Recombination in Gastric Cancer Cells. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl51619

BibTeX
@article{Li2026,
  author = {Li, Wenlong and Pei, Xinyue and Li, Yongpei and Lu, Yanji and Hong, Xian and Sui, Ming and Li, Qiang and Sun, Xueying and Wang, Jingqiu and Zhang, Enming and Liu, Yihan and Wang, Tao and Xu, Jing and Deng, Zhihui},
  title = {Arp2/3 Inhibition Synergizes With PARP Inhibitors by Impairing Homologous Recombination in Gastric Cancer Cells},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl51619}
}
Start for free →